Cargando…
Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until...
Autores principales: | Shah, Bela J, Mistry, Deval, Chaudhary, Navin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537689/ https://www.ncbi.nlm.nih.gov/pubmed/31148866 http://dx.doi.org/10.4103/ijd.IJD_633_18 |
Ejemplares similares
-
Real-world Efficacy and Safety of Apremilast Monotherapy in the Management of Moderate-to-severe Psoriasis
por: Shah, Bela J., et al.
Publicado: (2020) -
Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016) -
Pediatric psoriasis treated with apremilast
por: Smith, Rebecca L.
Publicado: (2016) -
Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris
por: Morita, Akimichi, et al.
Publicado: (2022) -
Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris
por: Meier, Katharina, et al.
Publicado: (2020)